Ethacizine hydrochloride is a Class Ic antiarrhythmic agent used for the treatment of cardiac arrhythmias; it exhibits longer duration of action compared to Flecainide; it suppresses depolarizing currents responsible for atrial and His-Purkinje ventricular conduction; it demonstrates negative chronotropic, negative inotropic, and coronary vasodilatory effects in vivo.